[1]李红兵,陈勇,曾建国,等.肝动脉化疗性栓塞结合Ⅱ期手术切除治疗巨块型外生型肝癌[J].国际放射医学核医学杂志,2010,34(1):49-52.[doi:10.3760/cma.j.issn.1673-4114.2010.01.013]
　LI Hong-bing,CHEN Yong,ZENG Jian-guo,et al.Treatment of massive extrahepatic growing hepatocellular carcinoma with TACE in combination with secondary resection[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):49-52.[doi:10.3760/cma.j.issn.1673-4114.2010.01.013]
点击复制

肝动脉化疗性栓塞结合Ⅱ期手术切除治疗巨块型外生型肝癌(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
34
期数:
2010年第1期
页码:
49-52
栏目:
临床放射医学
出版日期:
1900-01-01

文章信息/Info

Title:
Treatment of massive extrahepatic growing hepatocellular carcinoma with TACE in combination with secondary resection
作者:
李红兵1;  陈勇2;  曾建国1;  黄镇1;  程寿林1;  邱健青1
1. 518103, 深圳宝安区福永人民医院放射科;
2. 510515, 广州, 南方医科大学附属南方医院介入治疗科
Author(s):
LI Hong-bing1;  CHEN Yong2;  ZENG Jian-guo1;  HUANG Zhen1;  CHENG Shou-lin1;  QIU Jian-qing1
1. Department of Radiology, Fuyong People’s Hospital, Guangdong 518103, China;
2. Interventional Treatment Subjects, Nanfang Affiliated Hospital of Southern Medical University, Guangzhou 510515, China
关键词:
癌; 肝细胞; 血管造影术; 化学栓塞; 治疗性; 肝切除术; 肝外生长
Keywords:
Carcinoma; hepatocellular; Angiography; Chemoembolization; therapeutic; Hepatectomy; Extrahepatic growing
DOI:
10.3760/cma.j.issn.1673-4114.2010.01.013
摘要:
目的 探讨经导管动脉化疗性栓塞(TACE)结合Ⅱ期手术切除治疗巨块型外生型肝细胞癌(E-HCC)的可行性。方法 对5例E-HCC患者,先行TACE。术后1个月复查,CT显示病灶内碘油沉积欠佳者再行动脉造影和TACE术。待肿瘤缩小而不能经动脉途径有效给药时,行Ⅱ期手术切除。结果 5例患者行TACE共9次,平均1.8次。全部病例于TACE后1个月行CT检查,碘油在瘤体沉积表现为3型:完全填充型1例、致密型3例、斑片或环状型1例。5例患者均行Ⅱ期手术切除,3例成功行根治切除,2例因周边组织受侵、粘连严重而行姑息性切除。术后病理显示肿瘤有35%~100%(平均74.8%)的坏死。随访13~27月,1例存活,4例死亡,平均生存期为22.2月。无严重手术并发症发生。结论 TACE可使E-HCC坏死、缩小,提高Ⅱ期手术切除的机会。
Abstract:
Objective To investigate the efficacy and safety of transcatheter arterial chemoembolization (TACE) in combination with secondary resection in the treatment of massive extrahepatic growing hepatocellular carcinoma (E-HCC). Methods Five patients were involved in this study. CT reviewed after the first time of TACE treatment a month. If the lesion was not filled with satisfaction by chemotherapic agents lipiodol emulsion, arterial angiography and TACE were performed again. If failed to inject chemotherapic agents lipiodol emulsion into the lesions through the feeding arteries, the secondary resection was used. Results Five patients underwent TACE treatment 9 times, an average of 1.8 times. CT reviewed the iodized oil deposition in the tumor showed 3 types after all patient were treated first time of TACE a month:completely filled 1 case; dense filled 3 cases; spot or ring-type filled 1 case. After received the secondary resection, 3 cases of them were underwent curative resection successfully, the other 2 cases were used palliative resection due to surrounding tissue severe adhesion. Post-operative pathological specimen showed 35%~100% tumor necrosis (average 74.8%). During a follow-up of 13~27 months, 1 survived and 4 deaths, the median survival time was 22.2 months. No severe complications were observed. Conclusion TACE can induce obvious necrosis and shrinkage of E-HCC and increase the opportunities of secondary resection.

参考文献/References:

[1] Yeh CN,Lee WC,Jeng LB,et al.Pedunculated hepatocellular carcinoma:clinicopathologic study of 18 surgically resected cases.World J Surg,2002,26(9):1133-1138.
[2] Eriguchi N,Nonaka M,Yakabe S.A case report of pedunculated hepatocellular carcinoma,and review of case report in the literature.Nippon Shokakibyo Gakkai Zasshi,1997,94(7):503-507.
[3] Anthony PP,James K.Pedunculated hepatocellular carcinoma.Is it an entity?.Histopathology,1987,11(4):403-414.
[4] 周业江,王元正.外生性肝癌的诊断与治疗.中国现代医学杂志,2002,12(2):55-57.
[5] 叶胜龙.重视原发性肝癌的规范化治疗.中华肝脏病杂志,2004,12(8):449-450.
[6] 吴海江,董超,崔宁,等.外生型肝癌的诊断及介入治疗.医学影像学杂志,2006,16(10):1062-1064.
[7] 肖恩华,胡国栋,李锦清,陈敏山.化疗栓塞方法和肝细胞癌组织反应.实用放射学杂志,2001,17(5):324-326.
[8] 周建平,周伟平,丛文铭,等.大肝癌TACE后手术切除标本的病理研究.肝胆外科杂志,2004,12(1):11-13.
[9] Chung YH,Song IH,Song BC,et al.Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis.Cancer,2000,88(9):1986-1991.
[10] 游勇,谢宗贵,陈树平,等.外生性肝癌的血供特点及介入治疗.介入放射学杂志,2006,15(12):719-721.

相似文献/References:

[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
　Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
　Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[3]李欢欢,李素平,游金辉.小细胞肺癌伴副肿瘤综合征患者骨显像示肌肉摄取一例[J].国际放射医学核医学杂志,2014,38(2):140.[doi:10.3760/cma.j.issn.1673-4114.2014.02.016]
[4]戈畅,梁硕.化疗联合DC-CIK生物治疗非小细胞肺癌的临床价值及CT灌注成像的疗效评价[J].国际放射医学核医学杂志,2014,38(6):377.[doi:10.3760/cma.j.issn.1673-4114.2014.06.007]
　Ge Chang,Liang Shuo.The clinical value and CT perfusion evaluation in chemotherapy combined with DC-CIK biological treatment of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):377.[doi:10.3760/cma.j.issn.1673-4114.2014.06.007]
[5]黄少祥,樊体强.塞来昔布对非小细胞肺癌移植瘤的辐射增敏实验研究[J].国际放射医学核医学杂志,2013,37(3):150.[doi:10.3760/cma.j.issn.1673-4114.2013.03.006]
　HUANG Shao-xiang,FAN Ti-qiang.Radiosensitization on non-small cell lung cancer induced by celecoxib[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):150.[doi:10.3760/cma.j.issn.1673-4114.2013.03.006]
[6]龙再颖,汤春静,于立明,等.甲状腺乳头状癌术后刺激状态Tg与颈部淋巴结转移关系的研究[J].国际放射医学核医学杂志,2013,37(1):27.[doi:10.3760/cma.j.issn.1673-4114.2013.01.008]
　LONG Zai-ying,TANG Chun-jing,YU Li-ming,et al.The correlation between the stimulated thyroglobulin level after surgery in papillary thyroid carcinoma and cervical lymph node metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):27.[doi:10.3760/cma.j.issn.1673-4114.2013.01.008]
[7]于丽娟,李迎辞,王文志,等.PET-CT及PET-CT结合Lung VCAR软件对非小细胞肺癌肺门区淋巴结的诊断分析[J].国际放射医学核医学杂志,2012,36(6):323.[doi:10.3760/cma.j.issn.1673-4114.2012.06.002]
　YU Li-juan,LI Ying-ci,WANG Wen-zhi,et al.Value of PET-CT and PET-CT combined with Lung VCAR software in the diagnosis of hilar area lymph nodes of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):323.[doi:10.3760/cma.j.issn.1673-4114.2012.06.002]
[8]刘莉,杨景魁.125I粒子植入治疗非小细胞肺癌的护理及辐射防护[J].国际放射医学核医学杂志,2012,36(3):172.[doi:10.3760/cma.j.issn.1673-4114.2012.03.013]
　LIU Li,YANG Jing-kui.Radiation protective nursing intervene of 125I seed implantation in non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):172.[doi:10.3760/cma.j.issn.1673-4114.2012.03.013]
[9]朱晓琳,李强.肝腺瘤的影像诊断现状及进展[J].国际放射医学核医学杂志,2011,35(2):124.[doi:10.3760/cma.j.issn.1673-4114.2011.02.014]
　ZHU Xiao-lin,LI Qiang.Status and advances in imaging diagnsis of hepatic adenoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):124.[doi:10.3760/cma.j.issn.1673-4114.2011.02.014]
[10]梁吉祥,柴树德,郑广钧,等.CT引导下植入125I粒子治疗非小细胞肺癌切除术后局部复发的疗效[J].国际放射医学核医学杂志,2011,35(3):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
　LIANG Ji-xiang,CHAI Shu-de,ZHENG Guang-jun,et al.CT-guided percutaneous interstitial implantation of 125I for recurrent patients of postoperative non-small cell lung carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
[11]万绪明,许祖闪,侯红军.磁共振表观弥散系数变化率对肝细胞肝癌患者单次TACE术后疗效评价的应用价值[J].国际放射医学核医学杂志,2015,39(2):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
　Wan Xuming,Xu Zushan,Hou Hongjun.Applieation value of the change ratio of apparent diffusion coefficient in the therapeutic evaluation of hepatocellular carcinoma treated by single transcatheter arterial chemoembolization[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
[12]王振光,王洋洋.PET/CT显像在肝细胞肝癌诊断中的研究进展[J].国际放射医学核医学杂志,2015,39(2):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
　Wang Zhenguang,Wang Yangyang.The development of PET/CT imaging in the diagnosis of hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
[13]张一秋,石洪成.肝细胞癌肿瘤新生血管影像学评价的研究进展[J].国际放射医学核医学杂志,2013,37(1):60.[doi:10.3760/cma.j.issn.1673-4114.2013.01.015]
　ZHANG Yi-qiu,SHI Hong-cheng.Advances in assessment of imaging examination for tumor neoangiogenesis induced by hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):60.[doi:10.3760/cma.j.issn.1673-4114.2013.01.015]
[14]郑磊,李前伟.18F-氟脱氧葡萄糖PET在原发陛肝细胞癌中的应用[J].国际放射医学核医学杂志,2008,32(1):23.
　ZHENG Lei,LI Qian-wei.Application of positron emission tomography with 18F-fluorodeoxyglucose in hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(1):23.
[15]周云,刘璐,宋进华.经肝动脉灌注90Y微球治疗肝癌的研究进展[J].国际放射医学核医学杂志,2006,30(6):321.
　ZHOU Yun,LIU Lu,SONG Jin-hua.Clinical researched progress of intra-arterial radioembolization with 90Y-glass microspheres for treatment of hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):321.
[16]麻广宇,刘家金,徐白萱,等.11C-乙酸盐PET/CT显像在中、高分化肝细胞肝癌复发与转移监测中的应用研究[J].国际放射医学核医学杂志,2018,(4):312.[doi:10.3760/cma.j.issn.1673-4114.2018.04.004]
　Ma Guangyu,Liu Jiajin,Xu Baixuan,et al.Application of 11C-acetate PET/CT imaging in the detection of recurrence and metastasis of hepatocellular carcinoma with intermediate and high differentiation[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):312.[doi:10.3760/cma.j.issn.1673-4114.2018.04.004]
[17]赵竞,张占文,马慧,等.PET/CT显像剂18F-氟丙酸在肝癌中的生物学评估[J].国际放射医学核医学杂志,2018,(5):414.[doi:10.3760/cma.j.issn.1673-4114.2018.05.005]
　Zhao Jing,Zhang Zhanwen,Ma Hui,et al.Biological evaluation of PET/CT imaging agent 18F-fluoropropionic acid in hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):414.[doi:10.3760/cma.j.issn.1673-4114.2018.05.005]
[18]陈佩和,徐文贵,李小凤,等.肝细胞肝癌的葡萄糖代谢机制及在PET显像中的应用价值[J].国际放射医学核医学杂志,2018,(6):547.[doi:10.3760/cma.j.issn.1673-4114.2018.06.013]
　Chen Peihe,Xu Wengui,Li Xiaofeng,et al.Glycometabolism mechanism in hepatocellular carcinoma and its application in PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):547.[doi:10.3760/cma.j.issn.1673-4114.2018.06.013]

备注/Memo

备注/Memo:
收稿日期:2009-09-06。
通讯作者:陈勇,E-mail:cheny102@fimmu.com
更新日期/Last Update: 1900-01-01